InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Skyler Jay S. Director active across 3 companies, notably DEXCOM INC. Aggregated, 7 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €2.2m. Activity tracked since 20 May 2021. The latest transaction was filed on 6 June 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Skyler Jay S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
22,500 股Common StockSEC:0001193125-26-036147:0
45,000 股0Common StockSEC:0000950170-24-070638:0
20,000 股0Common StockSEC:0001209191-23-035600:0
3,876 股0Common StockSEC:0001093557-23-000143:0
900 股0Common StockSEC:0001093557-22-000121:0
6,264 股@ US$425.4519100.0% 占其流量Common StockSEC:0001093557-21-000172:0
822 股0Common StockSEC:0001093557-21-000147:0
7 条申报中的 7 条
About Skyler Jay S
SKYLER JAY S is a declarant linked to DEXCOM INC and Applied Therapeutics, Inc., where he is a Director, as well as Applied Therapeutics Inc., where he is a Director. He has 8 filings in total, and across the recent filings we track, sales total 4465259 EUR between 2021-05-25 and 2024-06-07, with no purchases reported.
